Cargando…

Correction: BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions

Detalles Bibliográficos
Autores principales:	Bery, Nicolas, Cruz-Migoni, Abimael, Bataille, Carole JR, Quevedo, Camilo E, Tulmin, Hanna, Miller, Ami, Russell, Angela, Phillips, Simon EV, Carr, Stephen B, Rabbitts, Terence H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2018
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075862/ https://www.ncbi.nlm.nih.gov/pubmed/30074480 http://dx.doi.org/10.7554/eLife.40515

Ejemplares similares

BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions
por: Bery, Nicolas, et al.
Publicado: (2018)

Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds
por: Cruz-Migoni, Abimael, et al.
Publicado: (2019)

Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment
por: Quevedo, Camilo E., et al.
Publicado: (2018)

A cell-based screening method using an intracellular antibody for discovering small molecules targeting the translocation protein LMO2
por: Bery, Nicolas, et al.
Publicado: (2021)

Pan RAS-binding compounds selected from a chemical library by inhibiting interaction between RAS and a reduced affinity intracellular antibody
por: Tanaka, Tomoyuki, et al.
Publicado: (2021)

Structural and functional characterization of a DARPin which inhibits Ras nucleotide exchange
por: Guillard, Sandrine, et al.
Publicado: (2017)

Developments in FRET- and BRET-Based Biosensors
por: Wu, Yuexin, et al.
Publicado: (2022)

Recent Developments in Targeting RAS Downstream Effectors for RAS-Driven Cancer Therapy
por: Tatli, Ozge, et al.
Publicado: (2021)

Development of a High-throughput NanoBRET Screening Platform to Identify Modulators of the RAS/RAF Interaction
por: Durrant, David E., et al.
Publicado: (2021)

The Ins and Outs of RAS Effector Complexes
por: Kiel, Christina, et al.
Publicado: (2021)

Competitive SPR using an intracellular anti-LMO2 antibody identifies novel LMO2-interacting compounds
por: Canning, Peter, et al.
Publicado: (2021)

Distinct Conformational Dynamics of Three G Protein-Coupled Receptors Measured Using FlAsH-BRET Biosensors
por: Bourque, Kyla, et al.
Publicado: (2017)

Ras functional proximity proteomics establishes mTORC2 as new direct ras effector
por: Kovalski, Joanna R., et al.
Publicado: (2019)

Ras protein abundance correlates with Ras isoform mutation patterns in cancer
por: Hood, Fiona E., et al.
Publicado: (2023)

The RAS-Effector Interface: Isoform-Specific Differences in the Effector Binding Regions
por: Nakhaeizadeh, Hossein, et al.
Publicado: (2016)

Targeting Ras with protein engineering
por: Tomazini, Atilio, et al.
Publicado: (2023)

Selection and Characterization of a Nanobody Biosensor of GTP-Bound RHO Activities
por: Keller, Laura, et al.
Publicado: (2019)

BRET Biosensor Analysis of Receptor Tyrosine Kinase Functionality
por: Siddiqui, Sana, et al.
Publicado: (2013)

Cloning, purification and structure determination of the HIV integrase-binding domain of lens epithelium-derived growth factor
por: Hannon, Clare, et al.
Publicado: (2018)

Ras Downstream Effector GGCT Alleviates Oncogenic Stress
por: He, Zaoke, et al.
Publicado: (2019)

REGA-SIGN: Development of a Novel Set of NanoBRET-Based G Protein Biosensors
por: Boon, Katrijn, et al.
Publicado: (2023)

Regulator of G-Protein Signaling 14 (RGS14) Is a Selective H-Ras Effector
por: Willard, Francis S., et al.
Publicado: (2009)

Glycyrrhetinic acid binds to the conserved P-loop region and interferes with the interaction of RAS-effector proteins
por: Zhang, Yuan, et al.
Publicado: (2019)

Expression, Purification, and Characterization of Ras Protein (BmRas1) from Bombyx mori
por: Quan, Yanping, et al.
Publicado: (2012)

A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS
por: Bery, Nicolas, et al.
Publicado: (2020)

BRET biosensors to study GPCR biology, pharmacology, and signal transduction
por: Salahpour, Ali, et al.
Publicado: (2012)

Intracellular immunization against HIV infection with an intracellular antibody that mimics HIV integrase binding to the cellular LEDGF protein
por: Bao, Leyuan, et al.
Publicado: (2017)

Association Rate Constants of Ras-Effector Interactions Are Evolutionarily Conserved
por: Kiel, Christina, et al.
Publicado: (2008)

Specific Conformational States of Ras GTPase upon Effector Binding
por: Baussand, Julie, et al.
Publicado: (2012)

Ras GTPases’ interaction with effector domains: Breaking the families’ barrier
por: Patel, Manishha, et al.
Publicado: (2013)

Dynamic regulation of RAS and RAS signaling
por: Kolch, Walter, et al.
Publicado: (2023)

Exploring the interactions of the RAS family in the human protein network and their potential implications in RAS-directed therapies
por: Bueno, Anibal, et al.
Publicado: (2016)

SIRT6 regulates Ras-related protein R-Ras2 by lysine defatty-acylation
por: Zhang, Xiaoyu, et al.
Publicado: (2017)

Abundant expression of ras proteins in Aplysia neurons
Publicado: (1986)

K-Ras protein as a drug target
por: McCormick, Frank
Publicado: (2016)

Proximal Protein Interaction Landscape of RAS Paralogs
por: Béganton, Benoît, et al.
Publicado: (2020)

The effects of mutant Ras proteins on the cell signalome
por: Takács, Tamás, et al.
Publicado: (2020)

Membrane Fusion and SNAREs: Interaction with Ras Proteins
por: Margiotta, Azzurra
Publicado: (2022)

The Ras-like protein R-Ras2/TC21 is important for proper mammary gland development
por: Larive, Romain M., et al.
Publicado: (2012)

WDR76 is a RAS binding protein that functions as a tumor suppressor via RAS degradation
por: Jeong, Woo-Jeong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_iiisq31fpfsnanvn4dij2jl7t3